Mark Identification

MATRIPTIMAB

Serial Number

90281316

Filing Date

Oct 27, 2020

Trademark by

Classification Information

Matriptimab is a novel antibody-drug conjugate that targets activated matriptase, a tumor antigen expressed almost exclusively on cancer cells